Annual Accounts Payable
$4.03 M
-$2.08 M-34.07%
December 31, 2023
Summary
- As of February 7, 2025, EWTX annual accounts payable is $4.03 million, with the most recent change of -$2.08 million (-34.07%) on December 31, 2023.
- During the last 3 years, EWTX annual accounts payable has risen by +$2.44 million (+154.75%).
- EWTX annual accounts payable is now -34.07% below its all-time high of $6.11 million, reached on December 31, 2022.
Performance
EWTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$5.65 M
-$1.15 M-16.94%
September 30, 2024
Summary
- As of February 7, 2025, EWTX quarterly accounts payable is $5.65 million, with the most recent change of -$1.15 million (-16.94%) on September 30, 2024.
- Over the past year, EWTX quarterly accounts payable has increased by +$331.00 thousand (+6.22%).
- EWTX quarterly accounts payable is now -16.94% below its all-time high of $6.80 million, reached on June 30, 2024.
Performance
EWTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
EWTX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.1% | +6.2% |
| 3 y3 years | +154.8% | +6.2% |
| 5 y5 years | +503.4% | +6.2% |
EWTX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -34.1% | +4.7% | -16.9% | +99.8% |
| 5 y | 5-year | -34.1% | +503.4% | -16.9% | +257.5% |
| alltime | all time | -34.1% | +503.4% | -16.9% | +257.5% |
Edgewise Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.65 M(-16.9%) |
| Jun 2024 | - | $6.80 M(+44.0%) |
| Mar 2024 | - | $4.72 M(+17.3%) |
| Dec 2023 | $4.03 M(-34.1%) | $4.03 M(-24.3%) |
| Sep 2023 | - | $5.32 M(+40.7%) |
| Jun 2023 | - | $3.78 M(-2.4%) |
| Mar 2023 | - | $3.88 M(-36.5%) |
| Dec 2022 | $6.11 M | $6.11 M(+6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $5.76 M(+103.6%) |
| Jun 2022 | - | $2.83 M(-47.0%) |
| Mar 2022 | - | $5.34 M(+39.0%) |
| Dec 2021 | $3.84 M(+143.2%) | $3.84 M(+67.7%) |
| Sep 2021 | - | $2.29 M(-18.6%) |
| Jun 2021 | - | $2.82 M(+73.7%) |
| Mar 2021 | - | $1.62 M(+2.6%) |
| Dec 2020 | $1.58 M(+136.9%) | $1.58 M |
| Dec 2019 | $667.00 K | - |
FAQ
- What is Edgewise Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual accounts payable year-on-year change?
- What is Edgewise Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly accounts payable year-on-year change?
What is Edgewise Therapeutics annual accounts payable?
The current annual accounts payable of EWTX is $4.03 M
What is the all time high annual accounts payable for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual accounts payable is $6.11 M
What is Edgewise Therapeutics annual accounts payable year-on-year change?
Over the past year, EWTX annual accounts payable has changed by -$2.08 M (-34.07%)
What is Edgewise Therapeutics quarterly accounts payable?
The current quarterly accounts payable of EWTX is $5.65 M
What is the all time high quarterly accounts payable for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly accounts payable is $6.80 M
What is Edgewise Therapeutics quarterly accounts payable year-on-year change?
Over the past year, EWTX quarterly accounts payable has changed by +$331.00 K (+6.22%)